# A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors

> **NCT07351903** · PHASE1 · RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** GK01 Injection

## Key facts

- **NCT ID:** NCT07351903
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-16
- **Primary completion:** 2028-10-15
- **Final completion:** 2029-02-14
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- Beijing Geekgene Technology Co., LTD

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07351903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07351903, "A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07351903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*